Consolidated net sales were $434.4 million in the third quarter of fiscal 2013, a 1.4 percent increase, compared to $428.3 million in the third quarter of fiscal 2012.
The company is working with sanitary authorities to control the outbreak by taking necessary actions, such as applying a vaccination program, among others.